These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

561 related items for PubMed ID: 17804135

  • 1. Open-label study of s-citalopram therapy of chronic fatigue syndrome and co-morbid major depressive disorder.
    Amsterdam JD, Shults J, Rutherford N.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan 01; 32(1):100-6. PubMed ID: 17804135
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV.
    Clin Ther; 2007 Nov 01; 29(11):2319-32. PubMed ID: 18158074
    [Abstract] [Full Text] [Related]

  • 3. A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms.
    Fraguas R, da Silva Telles RM, Alves TC, Andrei AM, Rays J, Iosifescu DV, Wajngarten M.
    Contemp Clin Trials; 2009 May 01; 30(3):205-11. PubMed ID: 19470312
    [Abstract] [Full Text] [Related]

  • 4. Escitalopram in the treatment of major depressive disorder in primary-care settings: an open-label trial.
    Chokka P, Legault M.
    Depress Anxiety; 2008 May 01; 25(12):E173-81. PubMed ID: 19006260
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness and safety of citalopram in hospitalized adolescents with major depression: a preliminary, 8-week, fixed-dose, open-label, prospective study.
    Shoval G, Nahshoni E, Gothelf D, Manor I, Golobchik P, Zemishlany Z, Weizman A, Zalsman G.
    Clin Neuropharmacol; 2011 May 01; 34(5):182-5. PubMed ID: 21926484
    [Abstract] [Full Text] [Related]

  • 6. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M, McCall WV, Krystal A, Wessel T, Rubens R, Caron J, Amato D, Roth T.
    Biol Psychiatry; 2006 Jun 01; 59(11):1052-60. PubMed ID: 16581036
    [Abstract] [Full Text] [Related]

  • 7. An open-label multicentric study of the tolerability and response to escitalopram treatment in Indian patients with major depressive disorder.
    Pinto C, Trivedi JK, Vankar GK, Sharma PS, Narasimha V.
    J Indian Med Assoc; 2007 Jul 01; 105(7):364, 366, 368 passim. PubMed ID: 18178988
    [Abstract] [Full Text] [Related]

  • 8. Escitalopram in the treatment of anxiety symptoms associated with depression.
    Bandelow B, Andersen HF, Dolberg OT.
    Depress Anxiety; 2007 Jul 01; 24(1):53-61. PubMed ID: 16937393
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of oral escitalopram as continuation treatment of intravenous citalopram in patients with major depressive disorder.
    Schmitt L, Tonnoir B, Arbus C.
    Neuropsychobiology; 2006 Jul 01; 54(4):201-7. PubMed ID: 17337913
    [Abstract] [Full Text] [Related]

  • 10. A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study.
    Brown ES, Vigil L, Khan DA, Liggin JD, Carmody TJ, Rush AJ.
    Biol Psychiatry; 2005 Dec 01; 58(11):865-70. PubMed ID: 15993860
    [Abstract] [Full Text] [Related]

  • 11. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.
    Honig A, Kuyper AM, Schene AH, van Melle JP, de Jonge P, Tulner DM, Schins A, Crijns HJ, Kuijpers PM, Vossen H, Lousberg R, Ormel J, MIND-IT investigators.
    Psychosom Med; 2007 Dec 01; 69(7):606-13. PubMed ID: 17846258
    [Abstract] [Full Text] [Related]

  • 12. Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine.
    Baldwin D, Bridgman K, Buis C.
    J Psychopharmacol; 2006 Jan 01; 20(1):91-6. PubMed ID: 16204325
    [Abstract] [Full Text] [Related]

  • 13. The effect of pain on outcomes in a trial of duloxetine treatment of major depressive disorder.
    Arnold LM, Meyers AL, Sunderajan P, Montano CB, Kass E, Trivedi M, Wohlreich MM.
    Ann Clin Psychiatry; 2008 Jan 01; 20(4):187-93. PubMed ID: 19034749
    [Abstract] [Full Text] [Related]

  • 14. Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder.
    Arnold LM, Hudson JI, Wang F, Wohlreich MM, Prakash A, Kajdasz DK, Chappell AS.
    Clin J Pain; 2009 Jan 01; 25(6):461-8. PubMed ID: 19542792
    [Abstract] [Full Text] [Related]

  • 15. A randomized controlled trial of antidepressant continuation for major depression following traumatic brain injury.
    Rapoport MJ, Mitchell RA, McCullagh S, Herrmann N, Chan F, Kiss A, Feinstein A, Lanctôt KL.
    J Clin Psychiatry; 2010 Sep 01; 71(9):1125-30. PubMed ID: 20441723
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of reboxetine compared with citalopram: a double-blind study in patients with major depressive disorder.
    Langworth S, Bodlund O, Agren H.
    J Clin Psychopharmacol; 2006 Apr 01; 26(2):121-7. PubMed ID: 16633139
    [Abstract] [Full Text] [Related]

  • 17. Mood and neuropsychological changes in women with midlife depression treated with escitalopram.
    Wroolie TE, Williams KE, Keller J, Zappert LN, Shelton SD, Kenna HA, Reynolds MF, Rasgon NL.
    J Clin Psychopharmacol; 2006 Aug 01; 26(4):361-6. PubMed ID: 16855452
    [Abstract] [Full Text] [Related]

  • 18. Patient-rated troubling symptoms of depression instrument results correlate with traditional clinician- and patient-rated measures: a secondary analysis of a randomized, double-blind, placebo-controlled trial.
    Pandina GJ, Revicki DA, Kleinman L, Turkoz I, Wu JH, Kujawa MJ, Mahmoud R, Gharabawi GM.
    J Affect Disord; 2009 Nov 01; 118(1-3):139-46. PubMed ID: 19321206
    [Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of s-citalopram in patients with co-morbid major depression and diabetes mellitus.
    Amsterdam JD, Shults J, Rutherford N, Schwartz S.
    Neuropsychobiology; 2006 Nov 01; 54(4):208-14. PubMed ID: 17337914
    [Abstract] [Full Text] [Related]

  • 20. "Functional" or "psychosomatic" symptoms, e.g. a flu-like malaise, aches and pain and fatigue, are major features of major and in particular of melancholic depression.
    Maes M.
    Neuro Endocrinol Lett; 2009 Nov 01; 30(5):564-73. PubMed ID: 20035251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.